Electronic structure and cytotoxic activity of 'half-mustard type' phenothiazines by MM3 and PM3 methods

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 3895-3899

  Kurihara, Teruo ^a   Nojima, Kazumichi ^a   Sakagami, Hiroshi ^b   Motohashi, Noboru ^c   Molnár, Joseph ^d  

^a JOSAI UNIVERSITY   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

'Half mustard type' phenothiazines; Cytotoxic activity; MM3 method; Multiple regression analysis; PM3 method

Indexed keywords

DNA; PHENOTHIAZINE DERIVATIVE;

ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DRUG SENSITIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; KIDNEY CANCER; LEUKEMIA; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

ALGORITHMS; COLONIC NEOPLASMS; ELECTRONS; ELECTROSTATICS; HUMANS; LETHAL DOSE 50; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUSTARD COMPOUNDS; PHENOTHIAZINES; REGRESSION ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032763614     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Motohashi N, Kurihara T, Shampa G, Dastidar SG, Chakrabarti A, Chakrabarty AN and Molnár J. Relationship between In vitro-in vivo antibacterial activity and theoretical calculation on "half-mustard type" phenothiazines. In: Non Antibiotics: A new class of unrecognized antimicrobics(Chakrabarty AN, Molnár J, Dastidar S and Motohashi N. eds). Chapter 21., New Delhi, NISCOM Publ., 1998, pp246-261.
2. Motohashi N, Kurihara T, Sakagami H, Szabo D, Csuri K and Molnár J: Chemical structure and tumor type specificity of "half-mustard type" phenothiazines. Anticancer Res 19: in press, 1999.
3. Motohashi N, Kurihara T, Sakagami H and Molnár J: Molecular orbital of cytotoxic "half-mustard type" phenothiazines. Anti-cancer Res 19: in press, 1999.
4. Kurihara T, Motohashi N, Sakagami H and Molnár J: Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl-phenothiazines. Anticancer Res 19: in press, 1999.
5. Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Nacsa J and Molnár J: The primary in vitro antitumor screening of "half-mustard type" phenothiazines. Anticancer Res 17: 3409-3423, 1997.
6. Motohashi N, Kawase M, Kurihara T, Hevér A, Nagy S, Oscovski I, Tanaka M and Molnár J: Synthesis and antitumor activity of 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkylurea as potential anticancer agents. Anticancer Res 16: 2525-2532, 1996.
7. Tripos, Inc: Alchemy 2000 Program, 1996.
8. Fujitsu: winMOPAC (version 1.0, 1997).
9. Motohashi N, Kurihara T, Kawase M, Hevér A, Tanaka M, Szabo D, Nacsa J, Yamanaka W, Kerim A and Molnár J: Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido- and chloroethyl-phenothiazines. Anticancer Res 17: 3537-3543, 1997.
10. Shah A, Gaveriya H, Motohashi N, Kawase M, Sakagami H, Satoh K, Saitoh S, Solymosi À, Wolfard K and Molnár J: Synthesis and reversal on mdr tumor cells of dihydropyrinines. Preparation for Arzneim-Forsch, 1999.
11. Berler BH, Merz KM and Kollman PA: Atomic charges derived from semi-empirical method. J Comp Chem 11: 431-439, 1990.